Thymosin beta 4 improves neurological functional outcome
March 9, 2010 by biotechconnection.com · Leave a Comment
Thymosin beta 4 improves neurological functional outcome
REGENERX BIOPHARMACEUTICALS, INC. announced that a research team from the Henry Ford Hospital in Detroit, MI reported that Thymosin beta 4 (T?4), administered to rats one day after embolic stroke, improved neurological functional outcome compared to control animals.
Read more on News-Medical-Net